MedLeanRx Review
Best for: Texas patients wanting physician-guided access to brand or compounded GLP-1
MedLeanRx is a physician-guided online weight-loss clinic serving Texas (based in Spring, TX) offering FDA-approved brand GLP-1s — Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo (orforglipron) — plus compounded and oral GLP-1. Licensed physicians review every patient after a ~5-minute assessment (24-48h), with medication shipped free and ongoing support. Program fees start around $99-$149/mo; for brand meds the fee is a clinical charge plus the cost of medication. Service is Texas-only; it publishes Privacy, Terms, and SMS policies and shows no LegitScript certification.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
MedLeanRx is a solid telehealth option with balanced features and pricing.
MedLeanRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $99/mo ($99-$149/mo clinical/membership fee; compounded shipped, but BRAND (Wegovy/Zepbound/Foundayo) is fee + cost of medication)
- What's included
- Medication · Consult · Shipping
- Availability
- 1 states
- FDA status
- No FDA warning letter on record
How we scored MedLeanRx
Each dimension is scored algorithmically from MedLeanRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.7/10At $149/mo, MedLeanRx runs about 12% below the $169 median for GLP-1 providers.
Effectiveness25%
7.8/10MedLeanRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.0/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.9/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-24).
Accessibility10%
5.2/10MedLeanRx operates in a limited 1-state footprint — check availability first.
Support10%
5.5/10MedLeanRx provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this MedLeanRx review
Last checked 2026-06-24- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 1 state
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications MedLeanRx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
$99-$149/mo clinical/membership fee; compounded shipped, but BRAND (Wegovy/Zepbound/Foundayo) is fee + cost of medication
Clinical fee; brand Zepbound billed as fee + cost of medication
Ready to get started?
Plans and promotions change often — check MedLeanRx's current pricing and active discounts before you decide.
What we like
- Offers FDA-approved brand GLP-1 — Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo (orforglipron) — plus compounded GLP-1 and oral options
- Physician-guided: licensed physicians review every patient, with a named clinician and ongoing clinical support
- Fast, low-friction start — a ~5-minute assessment, 24-48 hour provider review, and medication shipped with free shipping
- Program fees from $99-$149/mo; established Texas-licensed telehealth practice with a published address
Watch-outs
- Texas only — service is limited to patients in Texas (Houston, Dallas, Austin, San Antonio)
- For brand meds the monthly fee is a clinical charge 'plus the cost of medication' — true total runs higher than the $99-$149/mo headline
- Limited published policies (Privacy, Terms, SMS terms; no HIPAA notice found)
- No LegitScript certification displayed; compounding pharmacy not named
Is MedLeanRx worth it? Our verdict
MedLeanRx positions itself around one thing: Texas patients wanting physician-guided access to brand or compounded GLP-1. It runs $149/month — toward the affordable end of the market. Its standout is a needle-free oral option, which very few providers offer.
How much MedLeanRx actually costs
- Compounded semaglutide — $99/month
- Compounded tirzepatide — $149/month
That puts MedLeanRx below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Medications: what MedLeanRx prescribes
MedLeanRx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
MedLeanRx's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who MedLeanRx is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- are needle-averse and want a non-injectable option.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
MedLeanRx is available in 1 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
MedLeanRx earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
Ready to start with MedLeanRx?
Starting at $99/month. See current pricing and start your free consultation.
Alternatives to MedLeanRx
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this MedLeanRx review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with MedLeanRx?
Starting at $99/month. See current pricing and start your free consultation.